Table II.
ALB, GLB and TSB levels in each treatment group.
| A, ALB concentrations in different intervention groups | ||||||||
|---|---|---|---|---|---|---|---|---|
| Intervention group | N | ALB-0 (g/l) | ALB-1 (g/l) | P-value | ||||
| Phototherapy alone | 250 | 35.4±3.9 | 35.2±3.6 | 0.582 | ||||
| Phototherapy+IVIG | 20 | 34.3±4.3 | 32.4±5.3 | 0.586 | ||||
| Phototherapy+IVALB | 104 | 35.7±4.8 | 39.3±3.6 | <0.010 | ||||
| Phototherapy+IVIG+IVALB | 56 | 34.8±4.3 | 36.5±3.3 | 0.009 | ||||
| B, GLB concentrations in different intervention groups | ||||||||
| Intervention group | N | GLB-0 (g/l) | GLB-1 (g/l) | P-value | ||||
| Phototherapy alone | 250 | 21.3±4.1 | 18.5±4.2 | <0.010 | ||||
| Phototherapy+IVIG | 20 | 22.4±3.5 | 23.8±5.6 | 0.499 | ||||
| Phototherapy+IVALB | 104 | 23.0±3.9 | 16.6±4.5 | <0.010 | ||||
| Phototherapy+IVIG+IVALB | 56 | 22.9±4.7 | 22.6±4.3 | 0.451 | ||||
| C, TSB concentrations in different intervention groups | ||||||||
| Intervention group | N | TSB-0 (µmol/l) | TSB-1 (µmol/l) | P-value | ||||
| Phototherapy alone | 250 | 230.9±54.0a | 149.4±60.6b | – | ||||
| Phototherapy+IVIG | 20 | 222.3±57.8a | 144.1±27.3b | – | ||||
| Phototherapy+IVALB | 104 | 353.1±44.5 | 182.0±34.6b | – | ||||
| Phototherapy+IVIG+IVALB | 56 | 325.7±71.8 | 172.5±46.2b | – | ||||
GLB, globulin; ALB, albumin; TSB, total serum bilirubin; IVIG, intravenous immunoglobulin; IVABL, intravenous albumin; GLB-0, serum GLB levels at admission; GLB-1, serum GLB levels following intervention; ALB-0, serum ALB levels at admission; ALB-1, serum ALB levels following intervention; TSB-0, TSB levels at admission; TSB-1, TSB levels following intervention.
a
P<0.001 vs. IVALB and IVIG+IVALB
b
P<0.001 vs. TSB. Data are presented as mean ± standard deviation. Statistical analysis was performed using analysis of variance.